晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

交易中 10-13 11:57:47

6.495

-0.395

-5.73%

最高6.885	最低6.330	成交量5,672万
今开6.885	昨收6.890	日振幅8.06%
总市值279.35亿	流通市值279.35亿	总股本43.01亿
成交额3.67亿	换手率1.32%	流通股本43.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":6.495,"timestamp":1791863864250,"preClose":6.89,"halted":0,"volume":56722221,"delay":0,"changeRate":-0.05732946298984029,"floatShares":4301000000,"shares":4301000000,"eps":0.03,"marketStatus":"交易中","change":-0.395,"latestTime":"10-13 11:57:47","open":6.885,"high":6.885,"low":6.33,"amount":366810477,"amplitude":0.080552,"askPrice":6.495,"askSize":30000,"bidPrice":6.49,"bidSize":51000,"shortable":3,"etf":0,"ttmEps":-0.056,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1791864000000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":6.89,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"volumeRatio":2.123585,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"TPX.HK","impliedVol":0.6946,"impliedVolPercentile":0.8333},"requestUrl":"/m/hq/s/02228/wiki","defaultTab":"wiki","newsList":[{"id":"1157830362","title":"港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157830362","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157830362?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:38","pubTimestamp":1791855517,"startTime":"0","endTime":"0","summary":"10月13日，港股创新药概念股集体走低，$华昊中天医药-B(02563)$跌超11%，$金斯瑞生物科技(01548)$跌超10%，$药明合联(02268)$、$晶泰控股(02228)$跌超4%，$药明生物(02269)$、$歌礼制药-B(01672)$跌超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211977185.USD","SG9999002562.SGD","LU0359201612.USD","LU0561508036.HKD","LU0516422440.USD","LU0572944931.SGD","BK1161","LU0039217434.USD","MEDX","KURE","02268","HK0000320223.HKD","LU0244354667.USD","LU2778985437.USD","LU0819121731.USD","LNGR","BK1515","BK1574","LU0708995153.HKD","LU0516422366.SGD","BK4588","LU0326950275.SGD","LU1831875114.USD","LU0823426480.USD","LU0348827113.USD","09939","LU2476274308.USD","IBBQ","LU1720050803.USD","LU0348825331.USD","HK0000320264.USD","IE00B0JY6N72.USD","LU0463099449.HKD","LU0823426308.USD","BK1141","HK0000306685.HKD","BK4585","BK1583","LU0856984785.SGD","LU0128522744.USD","LU0588546209.SGD","LU1242518857.USD","BK1521","LU0359202008.SGD","LU3063872942.SGD","BK1610","LU0516423174.USD","01548","LU0052750758.USD","LU0128526141.USD","LU1688375341.USD","BK1576","BK1589","LU2476274720.SGD","LU2488822045.USD","LU0307460666.USD","BK1617","LU1794554557.SGD","KCAI","LU0708995583.HKD","LU1188198961.HKD","SG9999014674.SGD","02563","LU0029874061.USD","LU0327786744.USD","LU1242518931.SGD","02228","01672","LU0456846285.SGD","LU0828237510.HKD","LU1880383366.USD","LU0634319403.HKD","HK0000306701.USD","LU0456827905.SGD","02269","LU0051755006.USD","VXUS","06978","LU0029874905.USD","01477","SG9999002463.SGD","LU0348735423.USD","LU0417516902.SGD","LU2039709279.SGD","LU0181495838.USD","LU0228659784.USD","LU0320764243.SGD","LU0140636845.USD","LU0320764599.SGD","LU0516422952.EUR","LU0417516738.SGD","LU0540923850.HKD","LU0979878070.USD","LU0043850808.USD","LU0516423091.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112170297","title":"异动解读｜晶泰控股盘中下跌5.08%，AI制药板块集体回调拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1112170297","media":"行情直击","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112170297?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:37","pubTimestamp":1791855467,"startTime":"0","endTime":"0","summary":"10月13日，晶泰控股盘中下跌5.08%，报6.55港元，成交额5545.01万港元。消息面上，港股AI制药板块延续节后回调态势，板块内个股普遍走弱，晶泰控股作为AI制药核心标的随之承压。行业个股中，金斯瑞生物科技跌10.06%，英矽智能跌5.66%，药明合联跌4.06%，药明生物跌3.04%，药明康德跌1.92%，生命科学工具及AI制药标的全线走低。此前板块连续上涨后获利盘集中了结，叠加海外生物医药板块风险偏好下行，资金从高估值创新药标的撤离，拖累晶泰控股股价表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AI制药板块集体回调，晶泰控股随势下行","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675864833","title":"Lloyd S. Miller博士任Ailux首席医学官","url":"https://stock-news.laohu8.com/highlight/detail?id=2675864833","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675864833?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:37","pubTimestamp":1791851870,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1617","HELX","02228","BK1141","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185944999","title":"异动解读｜晶泰控股盘中下跌5.04%，创新药板块集体回调拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1185944999","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185944999?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:21","pubTimestamp":1791512464,"startTime":"0","endTime":"0","summary":"10月9日，晶泰控股盘中下跌5.04%，报6.785港元，成交额2.79亿港元。消息面上，创新药板块节后整体承压，港股生命科学工具及AI制药标的普遍走弱，板块联动效应明显。行业个股中，药明生物跌3.05%，药明康德跌3.45%，金斯瑞生物科技跌2.26%，英矽智能跌2.36%，药明合联跌3.53%。此前板块经历连续上涨后获利盘集中了结，叠加海外生物医药板块风险偏好下行，资金从高估值创新药标的撤离，晶泰控股作为AI制药核心标的随之调整。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"创新药板块集体回调，晶泰控股承压走低","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674611884","title":"人工智能板块走低 纳芯微（02676）跌8.07% OpenAI年化收入逊于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2674611884","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674611884?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:37","pubTimestamp":1791509850,"startTime":"0","endTime":"0","summary":"金吾财讯 | 人工智能板块走低，纳芯微 跌8.07%，胜宏科技跌5.37%，海光芯正跌4.24%，英诺赛科跌4.19%，长飞光纤光缆跌3.88%，澜起科技跌4.02%，天数智芯跌3.85%，广合科技跌3.91%，晶泰控股跌3.36%，剑桥科技跌3.61%，飞速创新跌3.35%。消息面上，据报道，OpenAI截至9月底年化收入接近500亿美元，较上月多个媒体所报道数字，低约200亿美元。报道提到，差异在于OpenAI与竞争对手Anthropic的计算方法不同，Anthropic将透过合作伙伴AWS及GoogleCloud等销售的收入也计算在内，OpenAI则不包括这类合作伙伴收入。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993367","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECY","QID","QSWN","MFIG","02676","03355","02577","QQQ","TQQQ","AQGX","09903","VUSE","QQA","NBDS","AIFD","CHAT","KOMP","NEWZ","QQQM","01989","PBOT","WPAI","06869","CWC","06809","DQJN","02228","TQQY","NJUL","01191","OGIG","GK","MVPS","PSQ","FWD","NJAN","QTOC","ARTY","161631","AGIX","AIQU","02476","TARK","688052","SQQQ","06166","AIBU","CPNQ","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179533848","title":"晶泰控股：温书豪增持，好仓比例升至15.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179533848","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179533848?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:31","pubTimestamp":1791451895,"startTime":"0","endTime":"0","summary":"温书豪于2026年10月7日在联交所场内以每股均价7.3093港元买入晶泰控股股份130.00万股，涉资约950.21万港元，属场内主动交易，即在二级市场直接买卖股份。温书豪此次增持前持有晶泰控股好仓6.79亿股，占比15.78%；增持后持股量为6.81亿股，好仓比例升至15.82%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673041962","title":"港股异动 | 晶泰控股升2%，获主席温书豪斥资950万港元购入130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673041962","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673041962?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:33","pubTimestamp":1791423190,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，$晶泰控股$升 2%。消息面上，10月7日晚，晶泰控股发布公告，获公司董事会主席、执行董事兼联合创始人温书豪博士告知，彼已动用自有资金，通过公开市场交易购入本公司合共130万股普通股，总代价约950万港元。公司指，温书豪拟继续购入更多股份，视乎当时市场状况及投资计划而定。董事会认为，温书豪通过市场自愿购入股份，反映他对该集团长远发展及前景充满信心。","market":"us","thumbnail":"https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504429.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1141","BK4585","HELS","02228","VXUS","BK1617","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673041178","title":"港股开盘受压 恒指低开0.41% 汇丰控股（00005）跌2.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673041178","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673041178?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:27","pubTimestamp":1791422846,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘受压，恒指低开0.41%，国企指数低开0.23%，恒生科技指数低开0.25%。汇丰控股跌2.40%，中国生物制药跌2.03%，华润电力跌1.97%，创科实业跌1.37%，万洲国际跌1.35%。剑桥科技低开2.01%，公司公告公布，拟配售1844.6万股。配售事项集资总额约为19.40亿港元，净额约19.30亿港元。初步转换价为每股H股128.82港元，较上交易日收市价114.30港元溢价约12.70%，可悉数转换为3598.33万股H股。乐动机器人低开1.52%，公司宣布，收购SABO-Maschinenfabrik GmbH全部股权，交易金额不超过600万欧元。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993270","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1808992512.USD","603083","03115","BK1183","IE0008368742.USD","IE00B29SXG58.USD","IE00BYTNYN87.SGD","BK1568","LU0348767384.USD","LU1282651048.USD","LU1642822792.SGD","SG9999001226.SGD","LU0039217434.USD","HK0000286598.CNH","09067","LU1366334578.USD","LU0231483743.USD","LU1251922891.USD","LU0488056044.USD","LU0516422366.SGD","SG9999004220.SGD","03033","00178","LU0370786039.SGD","BK1179","LU0029874061.USD","LU0348825331.USD","IE0031814852.USD","BK1116","BK1530","LU0051755006.USD","BK1543","LU0228659784.USD","LU0871576103.HKD","LU1719994722.HKD","BK1224","LU0594300419.USD","LU0828237510.HKD","LU0345776255.USD","LU0516422440.USD","LU0516423174.USD","IE0008369823.USD","LU0106259558.USD","BK1615","LU0588545490.SGD","03143","LU1960683339.HKD","LU1282651121.HKD","09618","LU0541502299.USD","09115","LU0543330566.HKD","IE00B3M56506.USD","SG9999002562.SGD","BK1502","LU0164865239.USD","BK1589","07300","BK1191","LU2187417386.USD","SG9999001069.SGD","IE00BZ08YR35.GBP","00836","02800","LU1152091754.HKD","02833","03032","LU1282649067.USD","LU1328277881.USD","SG9999011746.SGD","IE0009570106.USD","BK1555","LU1226287875.USD","02228","LU0541501648.USD","LU1226288170.HKD","LU1226287529.USD","01177","LU0791590937.USD","LU0634319403.HKD","LU0320764599.SGD","LU2045819591.USD","513600","IE00B5MMRT66.SGD","LU1282648689.USD","LU0320764755.SGD","LU1807302812.USD","03088","BK1577","01236","LU1303224171.USD","KURE","LU1770036033.HKD","LU2449936058.SGD","LU0531971595.HKD","LU0274383008.USD","LU0417516738.SGD","LU1044875133.USD","LU1282649810.SGD","LU0431992006.USD","LU1813983027.USD","LU0128526141.USD","IE00BZ08YT58.USD","LU0865486749.SGD","LU1152091168.USD","SG9999000327.SGD","IE00B543WZ88.USD","LU1951186391.HKD","LU0229945570.USD","LU2008162690.USD","LU0348814723.USD","07500","LU0287142896.SGD","LU0345775950.USD","LU0877626530.USD","LU0588545904.SGD","BK1149","BK1588","LU0417516902.SGD","LU1119993845.HKD","LU0327786744.USD","00288","LU0499858438.USD","LU0516423091.SGD","LU0348805143.USD","LU0307460666.USD","07226","BK1570","HSTECH","09088","BK1240","601600","LU2125910500.SGD","BK1594","IE00BYQNZ168.SGD","07200","LU1023057109.AUD","LU0228367735.SGD","LU0672654166.SGD","SBHMY","BK1521","LU0469268626.HKD","LU0227179875.USD","06166","TTNDY","BK1249","BK1572","IE00B031HW06.USD","03419","LU0261947096.USD","LU1008478684.HKD","LU2351347302.SGD","BK1617","LU0359201885.HKD","82800","00669","LU2929501877.USD","WHGLY","BK1603","BK1601","HK0000165453.HKD","LU0348816934.USD","LU0543330483.HKD","SG9999002950.SGD","03750","BK1591","LU1102505929.USD","HSHD.SI","LU0880133367.SGD","LU0072913022.USD","LU1993786604.SGD","LU0164880469.USD","LU1366334651.USD","JD","LU0797268264.HKD","LU2257852520.SGD","LU0149721374.USD","LU0540923850.HKD","LU1720050803.USD","LU0499858602.USD","LU1166156734.SGD","LU0048597586.USD","LU1224444064.USD","LU0588546209.SGD","LU1794554557.SGD","LU0149534421.HKD","LU0251144936.SGD","LU0384037296.USD","LU0588545730.USD","LU0868486357.SGD","BK1610","03037","MCHmain","IE0032431581.USD","LU0791591158.USD","IE00B0169N27.USD","300750","BK1513","HSBC","LU1481107354.HKD","LU0516422952.EUR","BK1237","IE00BGV7N243.SGD","LU0359201612.USD","LU1226288253.USD","LU0572944931.SGD","LU1770034418.SGD","03423","LU0259732245.USD","SG9999001051.SGD","LU0067412154.USD","LU0048388663.USD","LU0173614495.USD","SG9999001689.USD","BK1142","LU1105468828.SGD","LGFRY","00960","02837","LU0456846285.SGD","IE0034224299.USD","IE00B12V2V27.USD","LU0315178854.USD","89618","LU1102505762.USD","LU2226246903.HKD","BK1175","BK1575","LU0052750758.USD","SG9999002828.SGD","BK1602","03417","BK1125","LU0128522157.USD","BK1619","LU0348735423.USD","LU1044876610.USD","LU0029875118.USD","LU2039709279.SGD","LU0211977185.USD","LU0650527681.SGD","LU0607220059.USD","LU0293314216.USD","BK1231","BK1525","LU2177674079.SGD","LU0501845795.SGD","SGXZ90724238.SGD","IE00BZ08YS42.EUR","LU0359202008.SGD","LU0315179316.USD","LU0314109678.HKD","02600","BK1592","LU0918141705.HKD","LU1226287792.SGD","83115","01093","HSBA.UK","HSI","IE00B031J352.USD","BK1515","LU0163747925.USD","LU1044874839.SGD","LU0348766576.USD","07552","BK1141","LU0708995583.HKD","IE00B031HY20.USD","LU0205439572.USD","03067","LU0326950275.SGD","IE0008368411.USD","LU0456827905.SGD","LU0702159699.USD","HHImain","LU0084288322.USD","LU0456842615.SGD","LU0918141887.USD","LU2242644610.SGD","LU0048580855.USD","00005","CRPJY","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673419760","title":"港股异动 | 晶泰控股(02228.HK)高开近4% 获主席温书豪斥资950万港元购入130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673419760","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673419760?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:25","pubTimestamp":1791422703,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673001679","title":"晶泰控股(02228.HK)获董事会主席温书豪增持130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673001679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673001679?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:46","pubTimestamp":1791384387,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02228","BK1617","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121185655","title":"晶泰控股（02228）主席温书豪首批增持130万股 涉资约950万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121185655","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121185655?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:35","pubTimestamp":1791383734,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司（02228）10月7日公告披露，董事会主席、执行董事兼联合创始人温书豪博士于当日动用自有资金，在公开市场买入公司合共1,300,000股普通股，总代价约950万港元。此次购股为其2026年9月21日公布的增持计划下的首批交易。\n公司表示，是次增持已按照上市规则的通知及审批程序进行。温书豪博士计划在考虑当时市场状况及其投资安排的前提下，继续增持公司股份。\n公告称，根据目前可得信息并经合理查询后确认，完成上述股份收购后，公司已发行股份仍符合上市规则所要求的公众持股量。\n公司提醒股东及潜在投资者在买卖公司股份及其他证券时需审慎行事。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673016211","title":"晶泰控股：董事会主席温书豪增持130万股 耗资约950万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673016211","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673016211?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:35","pubTimestamp":1791383700,"startTime":"0","endTime":"0","summary":"南财智讯10月7日电，晶泰控股（02228.HK）发布自愿公告，公司董事会主席、执行董事兼联合创始人温书豪博士于2026年10月7日动用自有资金，通过公开市场交易购入公司130万股普通股，总代价约950万港元。此次收购为温书豪博士于2026年9月21日公布的增持股份计划项下的第一批收购。温书豪博士拟视乎市场状况及投资计划继续购入更多股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888979168.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888979168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02228","BK1617","BK1141","HELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131060167","title":"异动解读｜晶泰控股盘中下跌6.56%，创新药板块集体回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1131060167","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131060167?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:34","pubTimestamp":1791336882,"startTime":"0","endTime":"0","summary":"10月7日，晶泰控股盘中下跌6.56%，报7.825港元，成交额2092.75万港元。消息面上，晶泰控股所在的创新药及AI制药板块今日普遍走弱，行业个股中，金斯瑞生物科技跌14.94%，英矽智能跌8.01%，康龙化成跌3.64%，药明生物跌3.11%，药明康德跌1.19%，板块联动效应明显。此前晶泰控股于10月6日因生发管线进入IND-enabling阶段及ESMO大会催化创新药估值重塑预期，盘中一度上涨逾5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股盘中下跌，创新药板块集体走弱","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194461809","title":"晶泰控股更新9月股份变动月报表，已发行股份减少至4,301,475,179股","url":"https://stock-news.laohu8.com/highlight/detail?id=1194461809","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194461809?lang=zh_cn&edition=full","pubTime":"2026-10-06 19:27","pubTimestamp":1791286043,"startTime":"0","endTime":"0","summary":"晶泰控股于2026年10月6日公布截至2026年9月30日止月份的证券变动月报表。公告显示，公司法定股本维持100,000,000,000股不变，面值为每股0.00001美元，总额1,000,000美元。根据公告，本月公司已发行股份由上月末的4,303,469,679股变动至4,301,176,179股，减少2,293,500股。同时，新增299,000股被列为库存股份，月末公司库存股份为299,000股，已发行股份总数因此由4,303,469,679股降至4,301,475,179股。同时，299,000股购回后被列作公司库存股份。公告称，公司已符合相关公眾持股量要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673058257","title":"【热门行业】光遗传学获2026年诺奖：产业仍处早期，眼科赛道临床进度领先（附相关标的）","url":"https://stock-news.laohu8.com/highlight/detail?id=2673058257","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673058257?lang=zh_cn&edition=full","pubTime":"2026-10-06 18:22","pubTimestamp":1791282120,"startTime":"0","endTime":"0","summary":"诺奖落地的消息引发市场对光遗传学、脑科学相关赛道的关注。从行业发展阶段来看，光遗传学整体仍处于产业化早期，基础科研仍是核心需求，临床商业化尚未全面兑现。下游临床应用端，眼科赛道临床进度相对领先，但全行业目前尚无光遗传学产品完成全流程审批并获批上市，从临床试验到产品上市仍存在重大不确定性。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/YWU1MjY3ODMwOTg1Nzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YWU1MjY3ODMwOTg1Nzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993152","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU2476274308.USD","HK0000320264.USD","LU0051755006.USD","LU0979878070.USD","LU0211977185.USD","LU0128522744.USD","LU0307460666.USD","BK1574","LU1961090484.USD","LU0417516902.SGD","LU0708995583.HKD","LU0181495838.USD","LU0516423091.SGD","LU0456827905.SGD","LU0348767384.USD","01952","LU1794554557.SGD","LU0540923850.HKD","09688","09969","LU0823426308.USD","02269","BK1161","IBBQ","HK0000306685.HKD","LU0140636845.USD","01477","BK1191","02228","01548","LU0029874905.USD","LU0819121731.USD","LU1720050803.USD","IE00B0JY6N72.USD","09926","KURE","LU0634319403.HKD","LU0359201612.USD","BK1588","LU0572944931.SGD","LU0043850808.USD","LU0708995153.HKD","LU1688375341.USD","LU0456846285.SGD","LU0052750758.USD","BK1576","LU1242518931.SGD","LU0359202008.SGD","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673478033","title":"晶泰控股早盘涨逾5% 生发管线进入IND-enabling阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2673478033","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673478033?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:49","pubTimestamp":1791254940,"startTime":"0","endTime":"0","summary":"模拟交易客户端晶泰控股早盘涨逾5%。截至发稿，股价上涨4.66%，现报8.205港元，成交额1.08亿港元。晶泰科技近日宣布，其面向脱发治疗的创新药管线正式进入IND-enabling研究阶段。围绕候选分子的药效、安全性、成药性及CMC等关键要素的系统研究已经展开，为临床试验申请奠定基础。据悉，在防脱发领域，晶泰科技已经在消费健康端取得阶段性成果。值得注意的是，近期，晶泰科技多条自研及赋能管线陆续迎来IND获批、临床启动等关键节点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-06/doc-iniuhcmm5747602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673033592","title":"港股异动 | 晶泰控股(02228.HK)早盘涨超5% 生发管线进入IND-enabling阶段 为临床试验申请奠定基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2673033592","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673033592?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:25","pubTimestamp":1791253554,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1617","BK1141","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146598723","title":"异动解读｜晶泰控股盘中上涨5.36%，ESMO大会催化创新药估值重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=1146598723","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146598723?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:25","pubTimestamp":1791253506,"startTime":"0","endTime":"0","summary":"10月6日，晶泰控股盘中上涨5.36%，报8.26港元/股，成交额8591.92万港元。消息面上，2026年欧洲肿瘤内科学会披露的核心研究中，29项涉及国内药企参与开发的消息驱动创新药板块普涨。本次会议提升行业估值重塑预期，事件传导至AI制药及相关解决方案供应商。晶泰控股有限公司是一家主要为制药及材料科学产业提供研发解决方案及服务的公司，业务涵盖药物发现及智能机器人解决方案。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股盘中上涨，ESMO催化创新药估值重塑","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673734038","title":"创新药概念普升 歌礼制药-B（01672）涨11.78%、再鼎医药（09688）涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673734038","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673734038?lang=zh_cn&edition=full","pubTime":"2026-10-06 09:54","pubTimestamp":1791251688,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念普涨，截至发稿，歌礼制药-B 涨11.78%，再鼎医药涨6.55%，金斯瑞生物科技涨5.30%，晶泰控股涨4.40%，中国生物制药涨3.96%，三生制药涨3.41%，药明生物涨3.16%，康方生物涨3.11%，云顶新耀涨3.10%，四环医药涨2.82%。2026ESMO已公布LBA标题，29项LBA的试验药物由中国药企原研或参与开发，涉及约20家企业，其中5项进入主席研讨会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993103","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1574","LU0348827113.USD","LU2476274308.USD","LU0211977185.USD","01177","ZLAB","LU2778985437.USD","IE00BZ08YT58.USD","BK1161","KURE","BK4588","LU0052750758.USD","LU0320764599.SGD","LU0348735423.USD","LU0417516902.SGD","LU0708995153.HKD","SG9999002463.SGD","BK4139","159992","IE00BPRC5H50.USD","01672","LU1242518931.SGD","02228","LU0348766576.USD","MEDX","LU0320764243.SGD","02269","LU0140636845.USD","01477","IBBQ","HK0000306701.USD","BK1515","LU0516422366.SGD","LU0516423091.SGD","01530","BK1141","LU0348784397.USD","01548","09926","LU0359201612.USD","BK1521","LU0029874905.USD","01952","LU0823426308.USD","09688","LU0029874061.USD","LNGR","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673028817","title":"晶泰控股(02228)10月5日斥资1569.29万港元回购200.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673028817","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673028817?lang=zh_cn&edition=full","pubTime":"2026-10-05 19:37","pubTimestamp":1791200233,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)发布公告，该公司于2026年10月5日斥资1569.29万港元回购200.4万股股份，每股回购价格为7.78-7.88港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.1212},{"period":"1month","weight":-0.0058},{"period":"3month","weight":-0.0739},{"period":"6month","weight":-0.3198},{"period":"1year","weight":-0.4019},{"period":"ytd","weight":-0.2717}],"compareEarnings":[{"period":"1week","weight":0.0096},{"period":"1month","weight":-0.0215},{"period":"3month","weight":-0.0029},{"period":"6month","weight":-0.0646},{"period":"1year","weight":-0.0768},{"period":"ytd","weight":-0.053}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务主要包括早期苗头化合物生成到研究性新药的开发阶段，为临床试验的启动提供研究。智能机器人解决方案主要包括固态研发服务及自动化化学合成服务等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}